Johannes Griessner

Johannes Griessner

Auto-generated profile, based on publicly available information

Johannes Griessner

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Campus-Vienna-Biocenter 1, 1030, Vienna, Austria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2017 in Nature Methods
Verified
Journal Article
Closed access
PDF file
JSJohn R Stowers
John R Stowers
MHMaximilian Hofbauer
Maximilian Hofbauer
RBRenaud Bastien
Renaud Bastien
JGJohannes Griessner
Johannes Griessner
PHPeter Higgins
Peter Higgins
ASAndrew D Straw
Andrew D Straw

27 June 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
FGFlorian Groessl
Florian Groessl
TMThomas Munsch
Thomas Munsch
SMSusanne Meis
Susanne Meis
JGJohannes Griessner
Johannes Griessner
JKJoanna Kaczanowska
Joanna Kaczanowska
WHWulf Haubensak
Wulf Haubensak

30 November 2018 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
JGJohannes Griessner
Johannes Griessner
MPManuel Pasieka
Manuel Pasieka
VBVincent Boehm
Vincent Boehm
FGFlorian Grössl
Florian Grössl
JKJoanna Kaczanowska
Joanna Kaczanowska
WHWulf Haubensak
Wulf Haubensak
Benzodiazepines (BZDs) have been a standard treatment for anxiety disorders for decades, but the neuronal circuit interactions mediating their anxiolytic effect remain largely unknown. Here, we find that systemic BZDs modulate central amygdala (CEA) microcircuit activity to gate amygdala output. Combining connectome data with immediate early gene (IEG) activation maps, we identified the CEA as a primary site for diazepam (DZP) anxiolytic action. Deep brain calcium imaging revealed that brain-wide DZP interactions shifted neuronal activity in CEA microcircuits. Chemogenetic silencing showed that PKCδ + /SST − neurons in the lateral CEA (CEAl) are necessary and sufficient to induce the DZP anxiolytic effect. We propose that BZDs block the relay of aversive signals through the CEA, in part by local binding to CEAl SST + /PKCδ − neurons and reshaping intra-CEA circuit dynamics. This work delineates a strategy to identify biomedically relevant circuit interactions of clinical drugs and highlights the critical role for CEA circuitry in the pathophysiology of anxiety.

14 June 2018 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
PPPinelopi Pliota
Pinelopi Pliota
VBVincent Boehm
Vincent Boehm
FGFlorian Grössl
Florian Grössl
JGJohannes Griessner
Johannes Griessner
OVOrnella Valenti
Ornella Valenti
WHWulf Haubensak
Wulf Haubensak
Survival relies on optimizing behavioral responses through experience. Animals often react to acute stress by switching to passive behavioral responses when coping with environmental challenge. Despite recent advances in dissecting mammalian circuitry for Pavlovian fear, the neuronal basis underlying this form of non-Pavlovian anxiety-related behavioral plasticity remains poorly understood. Here, we report that aversive experience recruits the posterior paraventricular thalamus (PVT) and corticotropin-releasing hormone (CRH) and sensitizes a Pavlovian fear circuit to promote passive responding. Site-specific lesions and optogenetic manipulations reveal that PVT-to-central amygdala (CE) projections activate anxiogenic neuronal populations in the CE that release local CRH in response to acute stress. CRH potentiates basolateral (BLA)-CE connectivity and antagonizes inhibitory gating of CE output, a mechanism linked to Pavlovian fear, to facilitate the switch from active to passive behavior. Thus, PVT-amygdala fear circuitry uses inhibitory gating in the CE as a shared dynamic motif, but relies on different cellular mechanisms (postsynaptic long-term potentiation vs. presynaptic facilitation), to multiplex active/passive response bias in Pavlovian and non-Pavlovian behavioral plasticity. These results establish a framework promoting stress-induced passive responding, which might contribute to passive emotional coping seen in human fear- and anxiety-related disorders.